Advances in Genome Biology & Technology (AGBT)
Roche at the 2026 AGBT General Meeting
February 23-26, 2026
Orlando, Florida, USA
Signia by Hilton Orlando Bonnet Creek
Join us to start a new beginning
Congress Overview
The AGBT General Meeting is a premier assembly for global leaders, researchers, and industry innovators to showcase cutting-edge advancements in genome science and technology, spanning fields like cancer omics, artificial intelligence in research, and computational biology.
Sign up here to receive AXELIOS updates!
Register here to receive event recordings and future AXELIOS updates.
Explore a new world with Roche
Tuesday
February 24, 2026
5:30 - 7:30pm
Waterside Lanai
Stop by our table at the Women’s Networking Event
Connect with those shaping the future of genomics
9:45pm - 12:00am
Jade Lexington Suite
Enter a new dawn in genomics with AXELIOS 1
Step into the world of AXELIOS 1 at our special event
Wednesday
February 25, 2026
7:00 - 7:45am
Jade Lexington Suite
Explore the AXELIOS 1 Workflow:
From Library Prep to Flexible Sequencing
Option 1
4:45 - 6:10pm
Bonnet Creek
Ballroom I - VI
Access new data at our wine and poster session
RNA Exome Sequencing: Maximizing Insights into Gene Expression and Fusion Calling in a Single, Targeted Workflow using Low-input RNA
Authors: Amy E. Elias, Sandra Theall, Nikita Raymond Dsouza, Shobana Sekar, Mariana Fitarelli-Kiehl, Jieqiong Dai, Alejandro Quiroz Zarate, Lindsey Cambria
Thursday
February 26, 2026
7:00 - 7:45am
Jade Lexington Suite
Explore the AXELIOS 1 Workflow:
From Library Prep to Flexible Sequencing
Option 2
12:15 - 1:15pm
Bonnet Creek
Ballroom VII - XII
Join us to dive deeper at our workshop:
The Power of One
- Explore AXELIOS 1 workflow and methods
- Take a first look into new application highlights and operational considerations
- Hear the future outlook for AXELIOS 1
The AXELIOS 1 sequencing platform and sequencing by expansion (SBX) technology are in development and not commercially available. The content of this material reflects current study results and/or design goals. The AXELIOS 1 sequencing platform based on SBX technology will be launched for Research Use Only. Not for use in diagnostic procedures. AXELIOS is a trademark of Roche.
Meet the speakers
Mitu Chaudhary
International Business Leader, Sequencing Systems
Roche Diagnostics Solutions
Gustav Karlberg
Lifecycle Leader, Sequencing Systems
Roche Diagnostics Solutions
Johanna Whitacre
Network Lead, Sequencing Research & Development
Roche Diagnostics Solutions
Mark Kokoris
Head, SBX Technology
Roche Diagnostics Solutions
Edwin Cuppen
Scientific director
Hartwig Medical Foundation